Summary of Product Characteristics
last updated on the eMC:
30/07/2008
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 30/07/2008 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Jan-2008 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Sections 4.4, 4.5 and 4.8 : addition of undesirable effects: risk of corneal deposits or corneal opacity with patients presenting with compromised cornea and receiving polypharmacy.
Section 10: update of revision date: 01/2008
|
|
Updated on 29/09/2003 and displayed until 30/07/2008
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 30/07/2001 and displayed until 29/09/2003
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 06/09/1999 and displayed until 30/07/2001
|
Reasons for adding or updating:
|
|
|
|